Onward Medical N.V. (EBR:ONWD)

Market Cap	207.52M
Revenue (ttm)	-188.00K
Net Income (ttm)	-35.15M
Shares Out	44.63M
EPS (ttm)	-1.09
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	70,761
Average Volume	70,853
Open	4.850
Previous Close	4.860
Day's Range	4.650 - 4.850
52-Week Range	4.510 - 7.240
Beta	0.85
RSI	35.48
Earnings Date	Mar 31, 2025

About Onward Medical

Onward Medical N.V., a medical technology company, develops implantable neuro-stimulation Systems and non-invasive systems for electrical stimulation of specific areas of the spinal cord. The company engages in developing ARCEX, a transcutaneous system designed to improve upper extremity strength, function, and other symptoms in people with spinal cord injury (SCI); ARCIM, a minimally invasive implantable system to address blood pressure instability and other symptoms in people with SCI; and ARCBCI, which adds an implantable bran-computer inter...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2014
• Employees: 99
• Stock Exchange: Euronext Brussels
• Ticker Symbol: ONWD

Financial Performance

In 2023, Onward Medical's revenue was 532,000, a decrease of -75.23% compared to the previous year's 2.15 million. Losses were -36.18 million, 10.4% more than in 2022.